Alkermes Investigational Site

Orlando, Florida 32810

0 studies enrolling now · 11 studies all time

What they study most

Alcohol Dependence, Alcohol Use Disorder, Hepatic Impairment, Major Depressive Disorder, Refractory Major Depressive Disorder, Renal Impairment, Schizophrenia

Studies at this site

• Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) — Completed
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function — Completed
• Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function — Completed
• ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence — Completed